Biote (BTMD) Gains from Investment Securities (2021 - 2026)

Biote's Gains from Investment Securities history runs 6 years deep, the most recent figure standing at $11.5 million for Q1 2026.

• In Q1 2026, Gains from Investment Securities changed N/A year-over-year to $11.5 million; the TTM figure through Mar 2026 stood at $11.5 million (changed N/A YoY), while the FY2025 annual figure was $2.6 million, down 75.19% from the prior year.
• Gains from Investment Securities was $11.5 million for Q1 2026 at Biote, up from $2.6 million in the prior quarter.
• In the past five years, Gains from Investment Securities ranged from a high of $11.8 million in Q2 2023 to a low of -$3.4 million in Q2 2022.
• Historically, Gains from Investment Securities has averaged $2.7 million across 5 years, with a median of $420212.0 in 2024.
• The sharpest annual moves came in 2022 and 2023: Gains from Investment Securities sank 956.0% in 2022, then soared 4283.36% in 2023.
• A 5-year view of Gains from Investment Securities shows it stood at -$575000.0 in 2022, then soared by 748.28% to $3.7 million in 2023, then soared by 176.6% to $10.3 million in 2024, then plunged by 75.19% to $2.6 million in 2025, then soared by 349.24% to $11.5 million in 2026.
• The last three Gains from Investment Securities figures came in at $11.5 million (Q1 2026), $2.6 million (Q4 2025), and $4.5 million (Q3 2025), per Business Quant data.